Financial statements Bioconcept Capital
Balance sheet data of BIOCONCEPT CAPITAL
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 20 687 306,88 | 16 905 214,18 | 18 901 736,00 | 17 850 750,02 | 19 505 954,58 | 15 790 668,42 |
| A. Fixed assets | 8 210 540,18 | 8 198 364,74 | 8 186 189,30 | 8 174 714,80 | 8 173 310,00 | 8 214 215,00 |
| B. Current assets | 12 476 766,70 | 8 706 849,44 | 10 715 546,70 | 9 676 035,22 | 11 332 644,58 | 7 576 453,42 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - | - |
| Total liabilities | 20 687 306,88 | 16 905 214,18 | 18 901 736,00 | 17 850 750,02 | 19 505 954,58 | 15 790 668,42 |
| A. Equity | 9 252 039,86 | 9 386 645,62 | 9 701 391,91 | 10 772 455,93 | 11 565 010,61 | 10 155 876,57 |
| B. Liabilities and provisions for liabilities | 11 435 267,02 | 7 518 568,56 | 9 200 344,09 | 7 078 294,09 | 7 940 943,97 | 5 634 791,85 |
| I. Long-term liabilities | 746,14 | 0,00 | 661 030,54 | 143 011,41 | 0,00 | - |
| II. Short-term liabilities | 10 730 132,54 | 7 042 497,27 | 8 539 313,55 | 6 935 282,68 | 7 940 943,97 | 5 634 791,85 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.